Definitive Contract 75F40119C10054
- Not listed
- This is a $2,814,105.00 definitive contract awarded by the Food and Drug Administration (FDA) to the University of California, Los Angeles (UCLA) on August 27, 2021. The contract is for strengthening pharmacovigilance systems and adverse events reporting for maternal immunization safety in the Democratic Republic of Congo. The contract is a firm fixed-price award with a period of performance through March 14, 2026. The original solicitation was a Broad Agency Announcement (BAA) for advanced...
- This is a Cost No Fee definitive contract awarded by the Food and Drug Administration (FDA) to the University of California, Los Angeles (UCLA) to develop a biobank that can be used to characterize the durability and correlates of vaccine-induced and natural immunity to Ebola virus disease (EVD). The $7,332,682.00 contract has an ultimate completion date of March 22, 2025. UCLA will leverage its facilities, faculty expertise, and administrative capabilities to support this FDA initiative. The...
- The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $749,937 firm fixed-price contract to the University of California, Los Angeles (UCLA) to conduct research and development for the Ferrobotic Multiplexed Diagnostic Platform (FMDX) for at-home monitoring under Announcement of Opportunity #16 (AOI #16) - Lab at Home. This definitive contract has a period of performance ending on March 25, 2025 and does not...
- This is a firm fixed-price purchase order valued at $25,000.00 awarded by the Food and Drug Administration (FDA) to the University of California, Los Angeles (UCLA), doing business as the Office of Research Administration. The contract is for the provision of Occupational Safety and Health (OSH) training materials and safety training support to the Safety Training Consortium. The award has no set-aside designation and will be performed by UCLA at its facilities in Los Angeles, California. As the...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $749,000.00 firm fixed-price contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract involves research and development for scalable sequencing approaches to detect novel pathogens, with a focus on next-generation sequencing-based diagnostic tools for respiratory RNA virus pathogens. The contract has...
- This definitive firm fixed-price contract, valued at $249,582.00, was awarded by the Food and Drug Administration (FDA) to the University of Southern California (USC) to support literature research necessary to identify potential areas to study. The contract has a completion date of December 31, 2024 and was issued without a set-aside designation. USC, a prestigious private research university, regularly performs work for the federal government through contract and grant awards managed by its...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $265,649.00 firm fixed price purchase order to the University of California, Los Angeles (UCLA) to provide data files, syntax files, code books, metadata, and reports related to the UCLA COVID-19 Health Project. This award has a completion date of May 1, 2023 and was made on April 2, 2021. The contract does not have a set-aside designation. UCLA's Office of Research Administration, which supports the...
- This is a Firm Fixed Price delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the U.S. Department of Veterans Affairs, to the University of California, Los Angeles (UCLA) for RESEARCH ASSISTANCE SERVICES. The contract has a ceiling value of $15,900.00 and an ultimate completion date of May 13, 2026. This contract is not set aside and is awarded directly to UCLA as the prime contractor. UCLA is a U.S. state government entity,...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a Firm Fixed Price Purchase Order contract worth $49,874 by the Smithsonian Institution to provide assistance on the "ONE HEALTH PROTECT PROJECT" with a performance period ending on December 31, 2024. This contract has no set-aside designation. As a public research university and one of the largest employers in California, UCLA leverages its facilities, faculty expertise, and...
- This federal contract award is for a definitive contract with a potential value of $1,330,915.00 between the University of California, Los Angeles (UCLA) and an unspecified government agency. UCLA, through its Office of Research Administration, is providing research, training, and program implementation services as the prime contractor. The contract does not have a set-aside designation. UCLA is leveraging its facilities, faculty expertise, administrative capabilities, and partnerships to...
This is a Firm Fixed Price definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of California, Los Angeles (UCLA) under the Broad Agency Announcement FDAVAA-19-00123-A3 "Strengthening the Global Product Safety Net, Research Area #9". The contract has a potential value of $723,268.00 and a performance completion date of March 14, 2022. The contract is not set aside for any small business designation. UCLA is performing the work through its Office of Research Administration division, which provides research, training, and program implementation services to federal agencies. The parent organization for UCLA is the State of California Controller's Office. This contract supports the FDA's efforts to strengthen the global product safety net during the Coronavirus COVID-19 national emergency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Supplemental Agreement for work within scope | $0 | 11/30/21 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 11/5/21 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 5/3/21 | |
| P00004 | Other Administrative Action | $0 | 3/11/21 | |
| P00003 | Supplemental Agreement for work within scope | $123.4k | 3/3/21 |